Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
8,991,488
-
Share change
-
+3,875,025
-
Total reported value
-
$372,522,027
-
Put/Call ratio
-
44%
-
Price per share
-
$41.43
-
Number of holders
-
99
-
Value change
-
+$161,741,790
-
Number of buys
-
80
-
Number of sells
-
25
Institutional Holders of INSYS THERAPEUTICS INC NEW - COM NEW (INSYQ) as of Q1 2014
As of 31 Mar 2014,
INSYS THERAPEUTICS INC NEW - COM NEW (INSYQ) was held by
99 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,991,488 shares.
The largest 10 holders included
FMR LLC, Consonance Capital Management LP, ALLIANCEBERNSTEIN L.P., BlackRock Fund Advisors, VANGUARD GROUP INC, Tamarack Capital Management, LLC, JANUS CAPITAL MANAGEMENT LLC, Invesco Ltd., BlackRock Institutional Trust Company, N.A., and MORGAN STANLEY.
This page lists
99
institutional shareholders reporting positions in this security
for the Q1 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.